CSIMarket
 
Bgm Group Ltd  (BGM)
 

Bgm Group Ltd's Customers Performance

BGM



 
BGM's Source of Revenues During the corresponding time, Bgm Group Ltd saw a revenue deteriorated by -47.29 % year on year, While revenue at the Bgm Group Ltd's corporate clients

List of BGM Customers




for the same period Bgm Group Ltd revnue deteriorated by -47.29 % year on year,

List of BGM Customers

Bgm Group Ltd's Business Units
Oxytetracycline Licorice products and TCMD    91.07 % of total Revenue
Fertilizer    3.76 % of total Revenue
Heparin products and Sausage casing    9.25 % of total Revenue






Bgm Group Ltd's Comment on Sales, Marketing and Customers



The group operates in the global animal husbandry, pharmaceutical, and drug retail markets, supplying biopharmaceutical products including oxytetracycline API, crude heparin sodium, and licorice preparations. Its products are distributed across more than 20 provinces in China. The company serves pharmaceutical companies with licorice extracts, oxytetracycline APIs, and heparin sodium preparations; medical preparation companies with licorice liquid extract; the animal health sector with oxytetracycline tablets for chickens, turkeys, cattle, swine, and humans; and the food industry with sausage casings. Additionally, the group produces fertilizer products aimed at agricultural markets to enhance crop yield and soil quality. Notable products include Gan Di Xin®, Ahan® Antibacterial Paste, Qilian Shan® Licorice Extract, Qilian Shan® Oxytetracycline Tablets and API, Zhu Xiaochang® Sausage Casings, and Xiongguan® Organic and Organic-Inorganic Compound Fertilizers.





Bgm Group Ltd’s Comment on Sales, Marketing and Customers


The group operates in the global animal husbandry, pharmaceutical, and drug retail markets, supplying biopharmaceutical products including oxytetracycline API, crude heparin sodium, and licorice preparations. Its products are distributed across more than 20 provinces in China. The company serves pharmaceutical companies with licorice extracts, oxytetracycline APIs, and heparin sodium preparations; medical preparation companies with licorice liquid extract; the animal health sector with oxytetracycline tablets for chickens, turkeys, cattle, swine, and humans; and the food industry with sausage casings. Additionally, the group produces fertilizer products aimed at agricultural markets to enhance crop yield and soil quality. Notable products include Gan Di Xin®, Ahan® Antibacterial Paste, Qilian Shan® Licorice Extract, Qilian Shan® Oxytetracycline Tablets and API, Zhu Xiaochang® Sausage Casings, and Xiongguan® Organic and Organic-Inorganic Compound Fertilizers.








BGM's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bgm Group Ltd 2.06 24.11 -1.52 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Bgm Group Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bgm Group Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Bgm Group Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.